Objective. We studied the prevalence of nonalcoholic fatty liver disease (NAFLD) and its
clinical correlates in a population of patients with type 2 diabetes mellitus (T2DM). Methods …

Background This analysis was aimed to assess the incidence, regression, and correlated
factors of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes, which are poorly …

Background: Nonalcoholic fatty liver disease (NAFLD) is emerging as a public health issue
worldwide and is highly prevalent in patients with type 2 diabetes mellitus (T2DM). However …

Methods Three hundred and eighty-one T2DM outpatients who regularly attended a
Consulting Clinic in Cluj were retrospectivelly included. FLI, a surrogate steatosis biomarker …

Context Nonalcoholic fatty liver disease (NAFLD) prevalence is high, especially in patients
with obesity and type 2 diabetes, and is expected to rise steeply in the coming decades …

We investigated non‐alcoholic fatty liver disease (NAFLD) prevalence and its metabolic
associations in patients with type 1 diabetes (T1D), and in insulin‐naïve and insulin‐treated …

BACKGROUND & AIMS: To estimate the prevalence of non-alcoholic fatty liver disease
(NAFLD) in type 1 diabetic individuals, and to evaluate whether NAFLD is associated with …

Prevalence and risk factor analysis for the nonalcoholic fat... : Medicine Prevalence and risk
factor analysis for the nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus …

OBJECTIVE—To determine the prevalence of nonalcoholic fatty liver disease (NAFLD) in
type 2 diabetic population and to compare the prevalence of cardiovascular disease (CVD) …

Aim: The aim of this study was the evaluation of the prevalence of NAFLD in patients with
type 2 diabetes mellitus. Background: Non-alcoholic fatty liver disease (NAFLD) is an …